news Distribution Partner HealthX Lasers Launching Clinics Across India
MISSISSAUGA, ON, May 23, 2012/CNW/ - MedX Health Corp., (TSXV.MDX) with worldwide revenues in drug free, non-invasive low level laser light therapy and light imaging systems, announced that their distribution partner in India, HealthX Lasers (www.healthxlasers.com), is working with hospitals, physicians, clinics, therapists, and rehab facilities to establish HealthX Laser clinics offering MedX lasers to treat a wide range of medical conditions including smoking cessation and pain management. HealthX Lasers recently received funding to fully commercialize their clinic model as well as offer franchise opportunities to entrepreneurs across India. The full line of MedX Health laser and light devices for both rehab and sports medicine are now available in India.
"We are pleased to be working closely with {C}Mr. Sandeep Joshi{C}, President of HealthX Laser as he establishes his clinic and franchising model across {C}India{C}," said Steve Guillen, President & CEO, and "with the announcement earlier in the year that the Chinese FDA has approved our products we expect {C}India{C} and {C}China{C} to provide dramatic international revenue growth in the future."
About the Medical Device Market in India
Espicom Business Intelligence Ltd., says India's medical device market is exploding! {C}India{C} combines many opportunities and many challenges for the medical device industry. India's medical device market is currently the fourth largest market in Asia and is worth about $3 billion. With a projected growth 15% over the next five years, one cannot ignore India's potential and vast market opportunity. Indiahas a huge population in excess of one billion people and a growing middle class with access to high quality healthcare.
The Indian market for medical equipment and supplies ranks among the world's top 20 but, despite strong growth rates, the market remains disproportionately small with per capita spending of US$2. High quality, high tech products are sought after, particularly in the private sector hospitals and medical centers.
About MedX Health Corp.
MedX is a twelve (12) year old Canadian company, headquartered in Mississauga, Ontario (Toronto), and is a global leader in the design, manufacturing and distribution of quality low level laser and light therapy technologies for use in numerous medical settings, including rehab/chiropractic, dental, wound care, and veterinary medicine, providing patients with drug free and non-invasive treatment of tissue damage and pain. MedX laser and light products are FDA approved, Health Canadacleared, and CE Mark approved for use in North Americaas well as the European Union. Recently, MedX acquired MoleMate for the early diagnosis of skin cancer, and is expanding existing worldwide sales in the UK and Australia, through the launch of this technology in the US and Canada. www.simsys-molemate.com For a complete profile of MedX Health Corp. and its products visit www.medxhealth.com.
This press release does not constitute an offer of any securities for sale. This press release contains certain forward-looking statements within the meaning of applicable Canadian securities legislation. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ, including, without limitation, the company's limited operating history and history of losses, the inability to successfully obtain further funding, the inability to raise capital on terms acceptable to the company, the inability to compete effectively in the marketplace, the inability to complete the proposed acquisition and such other risks that could cause the actual results to differ materially from those contained in the company's projections or forward-looking statements. All forward-looking statements in this press release are based on information available to the company as of the date hereof, and the company undertakes no obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this press release.